Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Pelthos Therapeutics (PTHS) EBT Margin (2024 - 2025)

Pelthos Therapeutics has reported EBT Margin over the past 2 years, most recently at 173.24% for Q4 2025.

  • Quarterly results put EBT Margin at 173.24% for Q4 2025, down 58780.0% from a year ago — trailing twelve months through Dec 2025 was 212.14% (down 764250.0% YoY), and the annual figure for FY2025 was 301.91%, changed.
  • EBT Margin for Q4 2025 was 173.24% at Pelthos Therapeutics, up from 225.53% in the prior quarter.
  • Over the last five years, EBT Margin for PTHS hit a ceiling of 121784.57% in Q2 2025 and a floor of 50230.2% in Q2 2024.